← Evidence map

ArticleRheumatology and therapy2017

Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective.

Rebekah H Borse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28956301